Drug:
Reaction: DRY SKIN
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25068870 |
US |
59 | 1 |
Dry skin, Scratch, Rash, |
||||
DUPILUMAB, |
||||
| 402 | 25068898 |
US |
41 | 1 |
Dermatitis atopic, Dermatitis, Skin burning sensation, Erythema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 403 | 25068919 |
US |
8 | 1 |
Dry skin, Cough, Sleep disorder, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 404 | 25068929 |
US |
16 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 405 | 25068964 |
US |
6 | 1 |
Dry skin, Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 406 | 25069052 |
US |
59 | 2 |
Dry skin, Diarrhoea, |
||||
DUPILUMAB, |
||||
| 407 | 25069087 |
US |
35 | 2 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 408 | 25069144 |
US |
48 | 1 |
Dry skin, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 409 | 25069168 |
US |
24 | 1 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 410 | 25070487 |
US |
52 | 2 |
Dry skin, Eczema, Injection site pain, Accidental exposure to product, Exposure via skin contact, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 411 | 25070499 |
US |
47 | 2 |
Dry skin, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 412 | 25070508 |
US |
2 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 413 | 25070509 |
US |
71 | 1 |
Dry skin, Inappropriate schedule of product administration, Sleep disorder due to general medical condition, insomnia type, |
||||
DUPILUMAB, |
||||
| 414 | 25070540 |
US |
64 | 2 |
Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 415 | 25070556 |
US |
74 | 2 |
Dry skin, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 416 | 25070588 |
US |
64 | 1 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 417 | 25070594 |
US |
9 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 418 | 25070633 |
US |
40 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 419 | 25070667 |
US |
1 | 1 |
Blood iron decreased, Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 420 | 25070704 |
US |
71 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 421 | 25070731 |
US |
1 | |
Eczema, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 422 | 25070745 |
US |
19 | 1 |
Dry skin, Rebound effect, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 423 | 25070795 |
US |
28 | 1 |
Dry skin, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 424 | 25070806 |
US |
70 | 2 |
Dry skin, Sleep disorder, Skin haemorrhage, Skin fissures, Scratch, Pruritus, Injection site induration, Injection site pain, |
||||
DUPILUMAB, |
||||
| 425 | 25071141 |
US |
52 | 2 |
Respiratory arrest, Headache, Fatigue, Pruritus, Anxiety, Hypotension, Dizziness, Cold sweat, Confusional state, Illness, Pain in extremity, Nausea, Skin burning sensation, Drug ineffective, Dyspepsia, Malaise, Abdominal distension, Feeling hot, Dry mouth, Visual impairment, Flushing, Dry skin, Diarrhoea, Neck pain, Hypoaesthesia, Inflammation, Pyrexia, Decreased appetite, Hypoaesthesia oral, Sinus disorder, Dysphagia, Angina pectoris, Head discomfort, Joint range of motion decreased, Somnolence, |
||||
UPADACITINIB, |
||||
| 426 | 25071345 |
US |
44 | 1 |
Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, PREDNISONE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 427 | 25071463 |
US |
61 | 1 |
Cataract, Arthralgia, Exostosis, Hypoacusis, Intraocular pressure increased, Rash papular, Dry skin, |
||||
UPADACITINIB, |
||||
| 428 | 25073631 |
38 | 2 | |
Dry mouth, Lip dry, Dry skin, Skin fissures, Urticaria, Dyspnoea, Headache, Exposure during pregnancy, |
||||
OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, LABETALOL, IRON, MAGNESIUM, |
||||
| 429 | 25074054 |
54 | 2 | |
Weight increased, Alopecia, Dry skin, |
||||
LEVOTHYROXINE, |
||||
| 430 | 25061635 |
US |
72 | 2 |
Pain, Vision blurred, Pruritus, Hyperhidrosis, Rash, Unevaluable event, Acne, Abdominal distension, Dry skin, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, AMLODIPINE BESYLATE, |
||||
| 431 | 25061762 |
US |
2 | |
Dry skin, Feeling abnormal, Pain, Skin fissures, Headache, Incorrect dose administered, Product packaging quantity issue, Drug ineffective, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 432 | 25063183 |
US |
||
Pain, Skin tightness, Dry skin, Impaired work ability, Insomnia, |
||||
RELUGOLIX, RELUGOLIX, DAROLUTAMIDE, AMLODIPINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 433 | 25063353 |
CA |
16 | 2 |
Chills, Dizziness, Dry skin, Fatigue, Feeling abnormal, Flushing, Helminthic infection, Lip pruritus, Lip swelling, Oropharyngeal pain, Pain, Respiratory rate increased, Skin discolouration, Throat irritation, Urticaria, Therapy partial responder, |
||||
OMALIZUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 434 | 25063963 |
US |
68 | 2 |
Dry skin, Gastrointestinal disorder, |
||||
LENALIDOMIDE, ZOLPIDEM TARTRATE, AMOXICILLIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMOXICILLIN AND CLAVULANATE POTASSIUM, CETIRIZINE HCL, CETIRIZINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, GABAPENTIN, LENALIDOMIDE, |
||||
| 435 | 25064421 |
US |
66 | 2 |
Dry skin, Epistaxis, |
||||
ABATACEPT, |
||||
| 436 | 25064427 |
US |
37 | 1 |
Knee operation, Flatulence, Sleep disorder, Abdominal pain upper, Depression, Malaise, Chest pain, Dry skin, Asthenia, Fatigue, Dry mouth, Headache, Decreased appetite, Diarrhoea, Polyuria, Thirst, Dizziness, Underdose, Product dose omission issue, Therapy interrupted, |
||||
TOLVAPTAN, TOLVAPTAN, CLONIDINE, DICYCLOMINE HYDROCHLORIDE, DIVALPROEX SODIUM, GABAPENTIN, LORAZEPAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ZOLPIDEM TARTRATE, |
||||
| 437 | 25064572 |
US |
1 | |
Hypoacusis, Onychomadesis, Pigmentation disorder, Dry skin, Seizure, Constipation, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, METHIMAZOLE, |
||||
| 438 | 25065006 |
PL |
83 | |
Drug dependence, Diabetes mellitus inadequate control, Hypotension, Fall, Hyponatraemia, Cognitive disorder, Depression, Diabetes mellitus inadequate control, Osteoporosis, Mobility decreased, Hallucination, Malaise, Pericarditis, Cardiospasm, Atrial tachycardia, Muscular weakness, Anosmia, Lip swelling, Feeling abnormal, Dry skin, Pain, Eye pruritus, Amnesia, Diarrhoea, Facial pain, Dyspnoea, Palpitations, Chest pain, Tachycardia, Abdominal discomfort, Pyrexia, Angioedema, Ventricular tachycardia, Pruritus, Subarachnoid haemorrhage, Headache, Nausea, Vomiting, Disturbance in attention, Dizziness, Palmoplantar keratoderma, Migraine, Tinnitus, Peripheral swelling, Pain of skin, Tension headache, Arthralgia, Alopecia, Memory impairment, Sleep terror, Pruritus genital, Visual impairment, Diplopia, Blindness, Vasculitis, Transient ischaemic attack, COVID-19, Heart rate increased, Back pain, Abdominal pain upper, Muscle twitching, Hyperhidrosis, Rash papular, Dehydration, Anxiety, Abdominal discomfort, Insomnia, Carotid artery occlusion, Myocardial infarction, Pruritus, Off label use, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN CILEXETIL, METOPROLOL TARTRATE, METOPROLOL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, DAPAGLIFLOZIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, RAMIPRIL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROXYZINE, ALPRAZOLAM, ZOLPIDEM TARTRATE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ALLOPURINOL, FUROSEMIDE, SPIRONOLACTONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, ALBUTEROL SULFATE, ALBUTEROL, DABIGATRAN ETEXILATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, SIMVASTATIN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LINAGLIPTIN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, APIXABAN, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, NAPROXEN, NAPROXEN SODIUM, |
||||
| 439 | 25065187 |
CA |
2 | |
Bronchiolitis, Vaginal infection, Dry skin, Headache, Dizziness, Flushing, Grip strength decreased, Muscular weakness, Neck pain, Pain, Hypoaesthesia, Sinusitis, Oropharyngeal pain, Back pain, Drug ineffective, Insomnia, Vision blurred, Rash pruritic, Nasopharyngitis, Fatigue, Cough, Wheezing, Dyspnoea, Illness, Malaise, Product dose omission issue, Inappropriate schedule of product administration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 440 | 25056277 |
GB |
1 | |
Mental impairment, Gout, Pain, Swelling, Ill-defined disorder, Memory impairment, Inappropriate schedule of product administration, Depressed mood, Psoriasis, Dry skin, Groin pain, Erythema, Stress, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 441 | 25056333 |
US |
41 | 2 |
Rash pruritic, Dry skin, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 442 | 25056407 |
US |
1 | |
Snoring, Dry skin, Intentional dose omission, Unevaluable event, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 443 | 25056477 |
US |
2 | |
Dry skin, Skin exfoliation, Product use in unapproved indication, |
||||
DUPILUMAB, CEFPROZIL, FAMOTIDINE, FOLIC ACID, GABAPENTIN, METHADONE HYDROCHLORIDE, METHADONE, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, ROPINIROLE, LEVOTHYROXINE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 444 | 25056713 |
US |
64 | 2 |
Dry skin, Pruritus, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 445 | 25056715 |
US |
33 | 2 |
Dry skin, Pruritus, Injection site urticaria, |
||||
DUPILUMAB, |
||||
| 446 | 25056732 |
US |
36 | 2 |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 447 | 25057603 |
US |
60 | 2 |
Dry skin, |
||||
ABATACEPT, |
||||
| 448 | 25057944 |
US |
||
Muscle spasms, Stomatitis, Dry skin, Muscular weakness, Memory impairment, Dyspnoea, Fatigue, Arthralgia, |
||||
RELUGOLIX, RELUGOLIX, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OLMESARTAN MEDOXOMIL, ROSUVASTATIN CALCIUM, ENZALUTAMIDE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 449 | 25058569 |
US |
1 | |
Pericardial effusion, Pleural effusion, Cyst, Rash, Papule, Dizziness, Asthenia, Drainage, Headache, Tinnitus, Furuncle, Ulcer, Scar, Peripheral swelling, Joint swelling, Rash erythematous, Pruritus, Penile swelling, Penile swelling, Penile erythema, Tinea pedis, Pruritus, Rash, Dry skin, |
||||
EMPAGLIFLOZIN, |
||||
| 450 | 25058709 |
TH |
63 | 2 |
Pyrexia, Oropharyngeal pain, Feeding disorder, Dysstasia, Asthenia, Vomiting, Chills, Dizziness, Pain, Influenza like illness, Haematological infection, Headache, Syncope, Chest discomfort, Palpitations, Rash erythematous, Nausea, Dry mouth, Dry throat, Fatigue, Rash macular, Dry skin, |
||||
ALPELISIB, ALPELISIB, |
||||
| 451 | 25059074 |
PT |
76 | 1 |
Neutropenia, Rectal haemorrhage, Haemorrhoidal haemorrhage, Acute kidney injury, Atrial fibrillation, Respiratory failure, Hyperglycaemia, Cardiac failure, Neuropathy peripheral, Decreased appetite, Weight decreased, Dry skin, Erythema, Skin exfoliation, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, APIXABAN, APIXABAN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ROSUVASTATIN, ROSUVASTATIN, |
||||
| 452 | 25060119 |
US |
18 | 2 |
Rash, Discomfort, Sleep disorder, Dermatitis atopic, Dry skin, Product dose omission in error, |
||||
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MONTELUKAST, RUXOLITINIB, |
||||
| 453 | 25060129 |
US |
1 | |
Dry skin, Skin burning sensation, Pruritus, Rash, Dermatitis atopic, Skin ulcer, Injection site pain, |
||||
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DORZOLAMIDE, FAMOTIDINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RIFABUTIN, TAMSULOSIN HYDROCHLORIDE, |
||||
| 454 | 25060134 |
US |
63 | 1 |
Dry skin, Pruritus, Injection site pain, |
||||
DUPILUMAB, |
||||
| 455 | 25060140 |
US |
64 | 1 |
Rebound atopic dermatitis, Rash, Pruritus, Skin haemorrhage, Dry skin, Product dose omission issue, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 456 | 25060161 |
US |
53 | 1 |
Dermatitis, Dry skin, Pruritus, Skin exfoliation, Skin haemorrhage, Injection site erythema, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 457 | 25060164 |
US |
43 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 458 | 25060169 |
US |
41 | 2 |
Blister, Skin fissures, Eczema, Skin weeping, Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 459 | 25060206 |
US |
81 | 1 |
Alopecia, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 460 | 25060236 |
US |
58 | 2 |
Pruritus, Dry skin, Sleep disorder, |
||||
DUPILUMAB, |
||||
| 461 | 25060244 |
US |
46 | 1 |
Dry skin, Sleep disorder due to a general medical condition, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 462 | 25060250 |
US |
62 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Skin fissures, Rash, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 463 | 25060275 |
US |
35 | 2 |
Dry skin, Pruritus, Swelling of eyelid, Injection site pain, Dry eye, |
||||
DUPILUMAB, |
||||
| 464 | 25060658 |
US |
80 | 2 |
Neuropathy peripheral, Cervical spinal stenosis, Haemolysis, Transient ischaemic attack, Upper respiratory tract infection, Bronchospasm, Sleep disorder, Upper-airway cough syndrome, Alopecia, Dyspnoea exertional, Dyspepsia, Nocturia, Anxiety, Leukocytosis, Sarcopenia, Iron metabolism disorder, Dry skin, Erythema, Ecchymosis, Raynaud^s phenomenon, Skin lesion, Livedo reticularis, Cardiac murmur, Varicose vein, Fatigue, Rhinorrhoea, Dry mouth, Mouth ulceration, Dysphonia, Lymphadenopathy, Dysphagia, Skin hypopigmentation, Increased tendency to bruise, Temperature intolerance, Dry eye, Constipation, Abdominal distension, Affect lability, Blood creatine phosphokinase decreased, Red blood cell sedimentation rate abnormal, |
||||
ETANERCEPT, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, MOMETASONE FUROATE, MAGNESIUM OXIDE, CELECOXIB, LORATADINE, LORATADINE ORAL, ABATACEPT, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALBUTEROL SULFATE, ERGOCALCIFEROL, METHYLPREDNISOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, HYDROCODONE BITARTRATE, OXYCODONE, GABAPENTIN, AMOXICILLIN AND CLAVULANATE POTASSIUM, BACLOFEN, MONTELUKAST SODIUM, MONTELUKAST, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, ZOLMITRIPTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, EMPAGLIFLOZIN, LIRAGLUTIDE, LIRAGLUTIDE, DICLOFENAC SODIUM, COLCHICINE, PROPRANOLOL HYDROCHLORIDE, RIMEGEPANT SULFATE, UBROGEPANT, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, AZELAIC ACID, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, METHOTREXATE, TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION, |
||||
| 465 | 25055725 |
US |
51 | 2 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 466 | 25055742 |
US |
2 | |
Dry skin, Eyelid skin dryness, Eyelids pruritus, Erythema, Erythema of eyelid, Pruritus, Therapeutic product effect decreased, |
||||
DUPILUMAB, |
||||
| 467 | 25055871 |
US |
81 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 468 | 25055881 |
GB |
44 | 1 |
Dry skin, |
||||
| 469 | 25055885 |
US |
37 | 2 |
Exposure to allergen, Dry skin, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 470 | 25055919 |
US |
7 | 1 |
Acne, Skin fissures, Dry skin, Sleep disorder due to a general medical condition, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 471 | 25055951 |
US |
34 | 1 |
Dry skin, Sleep disorder, Skin haemorrhage, Skin weeping, Skin fissures, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 472 | 25055982 |
US |
63 | 2 |
Rebound eczema, Pruritus, Dry skin, Sleep disorder due to a general medical condition, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 473 | 25056011 |
US |
55 | 2 |
Dry skin, Skin fissures, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 474 | 25056012 |
US |
76 | 2 |
Dry skin, Skin fissures, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, |
||||
| 475 | 25056038 |
US |
55 | 2 |
Dry skin, Dry eye, |
||||
DUPILUMAB, |
||||
| 476 | 25054585 |
US |
76 | 1 |
Dry skin, Skin swelling, Contusion, Back disorder, Pruritus, |
||||
DUPILUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MELATONIN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, HYDROCHLOROTHIAZIDE, |
||||
| 477 | 25054619 |
US |
2 | 2 |
Erythema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 478 | 25054624 |
US |
2 | 2 |
Skin fissures, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 479 | 25054646 |
US |
47 | 1 |
Dermatitis atopic, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, |
||||
| 480 | 25054732 |
US |
15 | 2 |
Dry skin, Rash, Incorrect dose administered, |
||||
DUPILUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, IRON, |
||||
| 481 | 25054917 |
US |
1 | |
Malignant melanoma, Nausea, Dry skin, |
||||
IBRUTINIB, IBRUTINIB, |
||||
| 482 | 25054956 |
US |
||
Brain fog, Therapeutic response shortened, Fatigue, Dry skin, Muscular weakness, |
||||
RISANKIZUMAB-RZAA, |
||||
| 483 | 25055072 |
US |
51 | 1 |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 484 | 25055504 |
US |
31 | 2 |
Dermatitis atopic, Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 485 | 25048228 |
US |
1 | |
Hypoacusis, Fatigue, Fatigue, Ear congestion, Decreased appetite, Weight decreased, Asthenia, Upper respiratory tract infection, Dry skin, Diarrhoea, Cognitive disorder, |
||||
PIRFENIDONE, |
||||
| 486 | 25048457 |
US |
57 | 2 |
Dry skin, Skin exfoliation, Headache, |
||||
CLADRIBINE, |
||||
| 487 | 25048465 |
US |
4 | 1 |
Pyrexia, Dry skin, Abdominal discomfort, Product dose omission issue, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE ORAL, |
||||
| 488 | 25049068 |
CA |
39 | 2 |
Concussion, Discomfort, Dry skin, Flushing, Hypersensitivity, Illness, Weight decreased, Nausea, Oropharyngeal pain, Pyrexia, Insulin-requiring type 2 diabetes mellitus, Urticaria, Vomiting, Therapeutic response decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, THYROID, IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,, THYROID, UNSPECIFIED, |
||||
| 489 | 25049188 |
US |
45 | 2 |
Dry skin, Night sweats, Increased appetite, |
||||
DULAGLUTIDE, |
||||
| 490 | 25049456 |
CA |
63 | 2 |
Death, Dry mouth, Pruritus, Dry skin, Weight decreased, Hepatic enzyme increased, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 491 | 25049799 |
GB |
44 | 1 |
Dry skin, |
||||
| 492 | 25050256 |
BR |
51 | 2 |
Anaemia, Platelet count decreased, Decreased immune responsiveness, Skin discolouration, Ageusia, Oral discomfort, Gastritis, Oral disorder, Angular cheilitis, Nail cuticle fissure, Skin burning sensation, Depression, Discouragement, Constipation, Pruritus, Diarrhoea, Epistaxis, Acne, Skin exfoliation, Skin fissures, Abdominal pain, Dry skin, Dry mouth, Asthenia, Nausea, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 493 | 25050566 |
35 | 1 | |
Dry skin, |
||||
DUPILUMAB, PHENTERMINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SERTRALINE, LEVOTHYROXINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, POLYETHYLENE GLYCOL 3350, |
||||
| 494 | 25050585 |
BR |
65 | 2 |
Decreased immune responsiveness, Metastases to bone, Nasal dryness, Limb mass, Ill-defined disorder, Piercing associated complication, Skin exfoliation, Ear haemorrhage, Vulvovaginal pruritus, Laboratory test abnormal, Adverse reaction, Agitation, Sluggishness, Somnolence, Hair colour changes, Drug intolerance, Feeling hot, Decreased immune responsiveness, Decreased immune responsiveness, Contusion, Tooth loss, Musculoskeletal stiffness, Choking sensation, Muscular weakness, Burning sensation, Skin discolouration, Depressed mood, Cough, Dry mouth, Dry skin, Pruritus, Peripheral swelling, Dyspnoea, Fungal infection, Limb discomfort, Asthenia, Rash macular, Fatigue, Asthenia, Arthralgia, |
||||
FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 495 | 25051000 |
68 | 2 | |
Alopecia, Hot flush, Dry skin, Weight increased, Feeling abnormal, Disturbance in attention, Sleep disorder, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, MAGNESIUM, |
||||
| 496 | 25051066 |
US |
68 | 2 |
Dry eye, Dry skin, Skin exfoliation, Eye pruritus, Eye pain, Pruritus, Eye irritation, Product complaint, |
||||
KETOTIFEN FUMARATE, |
||||
| 497 | 25052426 |
US |
||
Dry skin, |
||||
| 498 | 25052427 |
US |
||
Dry skin, Photosensitivity reaction, Therapeutic response unexpected, |
||||
| 499 | 25052429 |
US |
||
Skin burning sensation, Hypersensitivity, Sensitive skin, Urticaria, Rash papular, Dry skin, Skin exfoliation, |
||||
ADAPALENE, SALICYLIC ACID, SALICYLIC ACID, |
||||
| 500 | 25052430 |
US |
||
Dry skin, Skin burning sensation, Erythema, Skin exfoliation, Skin irritation, Rash papular, |
||||
ADAPALENE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28